By Dr. Priyom Bose, Ph.D. Sep 2 2021 Reviewed by Benedette Cuffari, M.Sc. Scientists across the globe have worked at record speed to develop vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19). Several of these vaccines have received emergency use authorization (EUA) from...
by University of Virginia Ebony Hilton, MD, receives the first COVID-19 vaccine administered at UVA Health. Credit: UVA Health New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna COVID vaccines. The findings are some of the earliest to compare the two vaccines’ antibody responses head-to-head....
by Bob Yirka , Medical Xpress SARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIH A team of researchers affiliated with several institutions in Israel has found evidence that suggests healthcare workers are more likely to become infected with COVID-19 at home than on the job. They...
by Bill Hathaway, Yale University Credit: Michael S. Helfenbein When it comes to long-lasting protection against COVID-19, antibodies are our biggest allies, a new Yale University study shows. Since the emergence of the SARS-CoV-2 virus, the relative contributions of the different parts of our immune system arsenal—particularly those of T cells, which destroy infected cells from...
About 50 million people worldwide have epilepsy. The neurological disease causes seizures that are caused by disturbances in the electrical activity of the brain and can lead to premature death. Epilepsy can be treated with cheap medicine, but patients in low middle income countries are rarely diagnosed because of a lack of examination equipment and...
UNIVERSITY OF GOTHENBURG IMAGE: MAX LEVIN OCH SARA BJURSTEN, SAHLGRENSKA ACADEMY, UNIVERSITY OF GOTHENBURG. CREDIT: PHOTO BY ANNA REHNBERG. Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy. Now care staff can use a simple...
by Garvan Institute of Medical Research DNA double helix. Credit: Arek Socha By analyzing genomic data from more than 30,000 people, an international team has revealed thousands of new regulatory regions that control disease-linked genes—a resource that is now available to researchers worldwide. The findings, co-led by the Garvan Institute of Medical Research and published today...
by University of California, Los Angeles A 12 lead ECG showing atrial fibrillation at approximately 150 beats per minute. Credit: James Heilman, MD/Wikipedia/CC BY-SA 3.0 Direct-acting oral anticoagulants such as apixaban are the most widely used medications of this type in people with atrial fibrillation, yet 26% to 45% of people fail to properly adhere to...
by Perelman School of Medicine at the University of Pennsylvania Credit: CC0 Public Domain New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the...
by The Mount Sinai Hospital Mount Sinai scientists created an AI-based, automated system that learns to read patient data from electronic health records. Here the system identified dementia cases (purple dots) from a database of nearly 2 million patients (blue dots). Credit: Glicksberg lab, Mount Sinai, N.Y., N.Y. In an article published in the journal Patterns, scientists...
